Artificially intelligent software has been developed to enhance medical treatments that use jets of electrified gas known as plasma. The computer code predicts the chemicals emitted by plasma devices, which can be used to treat cancer, promote healthy tissue growth and sterilize surfaces.
The plasma studied in the experiments is known as cold atmospheric plasma (CAP). When the CAP jet is turned on, numerous chemical species in the plasma take part in thousands of reactions. These chemicals modify the cells undergoing treatment in different ways, depending on the chemical composition of the jet. While scientists know that CAPs can be used to kill cancer cells, treat wounds and kill bacteria on food, it’s not fully understood why.
“This research is a step toward gaining a deeper understanding of how and why CAP jets work and could also one day be used to refine their use,” said Yevgeny Raitses, a managing principal research physicist at the U.S. Department of Energy’s Princeton Plasma Physics Laboratory (PPPL).
The project was completed by the Princeton Collaborative Low Temperature Plasma Research Facility (PCRF), a collaboration between researchers at PPPL and the George Washington University (GWU).
PPPL has a growing body of work that combines its 70 years of pioneering plasma research with its expertise in AI to solve societal problems. The Lab’s mission extends beyond using plasma to generate fusion power to its use in fields such as medicine and manufacturing, among others.
The software uses an approach known as a physics-informed neural network (PINN). In a PINN, data is organized into parts called nodes and neurons. The flow of the data mimics the way information is processed in the human brain. Laws of physics are also added to the code.
“Knowing what comes out of the jet is very important. Knowing what comes out accurately is very difficult,” said Sophia Gershman, a lead PPPL research engineer from the PCRF who worked on this collaborative project. The process would require several different devices to collect different kinds of information about the jet.
“In practical studies, it is difficult to go and utilize all of the various technologically advanced diagnostics all at once for each device and for various types of surfaces that we treat,” Gershman explained.
Calculating the chemical composition one nanosecond at a time
Li Lin, a research scientist from GWU and the paper’s primary author, said it’s also difficult to calculate the chemicals in a CAP jet because the interactions need to be considered a nanosecond at a time.
“When you consider that the device is in operation for several minutes, the number of calculations makes the problem more than simply computationally intensive. It’s practically impossible,” Lin said. “Machine learning allows you to bypass the complicated part.”
The project began with a small set of real-world data that was gathered using a technique known as Fourier-transform infrared absorption spectroscopy. The researchers used that small dataset to create a broader set of data. That data was then used to train the neural network using an evolutionary algorithm, which is a type of computer code inspired by nature that searches for the best answers using a survival-of-the-fittest approach.
Several successive batches of data are generated using slightly different approaches, and only the best datasets from each round are carried through to the next round of training until the desired results are achieved.
Ultimately, the team was able to accurately calculate the chemical concentrations, gas temperature, electron temperature and electron concentration of the cold atmospheric plasma jet based on data gathered during real-world experiments.
In a cold atmospheric plasma, the electrons—small, negatively charged particles—can be very hot, though the other particles are close to room temperature. The electrons can be at a low enough concentration that the plasma doesn’t feel hot or burn the skin while still being able to have a significant effect on the targeted cells.
On the path to personalized plasma treatment
Michael Keidar, the A. James Clark Professor of Engineering at GWU and a frequent collaborator with PPPL who also worked on this project, said the long-term goal is to be able to perform these calculations fast enough that the software can automatically adjust the plasma during a procedure to optimize treatment. Keidar is currently working on a prototype of such a “plasma adaptive” device in his lab.
“Ideally, it can be personalized. The way we envision it, you treat the patient, and the response of every patient will be different,” Keidar explained. “So, you can measure the response in real-time and then try to inform, using feedback and machine learning, the right settings in the plasma-producing device.”
More research needs to be done to perfect such a device. For example, this study looked at the CAP jet over time but at only one point in space. Further research would need to broaden the work so it considers multiple points along the jet’s output stream.
The study also looked at the plasma plume in isolation. Future experiments would need to integrate the surfaces treated by the plasma to see how that impacts the chemical composition at the treatment site.
More information: Li Lin et al, Data-driven prediction of the output composition of an atmospheric pressure plasma jet, Journal of Physics D: Applied Physics (2023). DOI: 10.1088/1361-6463/acfcc7
![](https://www.nanoappsmedical.com/wp-content/uploads/2017/05/spacer.jpg)
News
Breakthrough in Antimicrobial Technology with Cinnamon-Based Nanokiller
The need for innovative antimicrobial agents has become increasingly urgent due to the rise of antibiotic-resistant pathogens and the persistent threat of infections acquired during hospital stays. Traditional antibiotics and antiseptics are often ineffective [...]
The Silent Battle Within: How Your Organs Choose Between Mom and Dad’s Genes
Research reveals that selective expression of maternal or paternal X chromosomes varies by organ, driven by cellular competition. A new study published today (July 26) in Nature Genetics by the Lymphoid Development Group at the MRC [...]
Study identifies genes increasing risk of severe COVID-19
Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in [...]
Small regions of the brain can take micro-naps while the rest of the brain is awake and vice versa
Sleep and wake: They're totally distinct states of being that define the boundaries of our daily lives. For years, scientists have measured the difference between these instinctual brain processes by observing brain waves, with [...]
Redefining Consciousness: Small Regions of the Brain Can Take Micro-Naps While the Rest of the Brain Is Awake
The study broadly reveals how fast brain waves, previously overlooked, establish fundamental patterns of sleep and wakefulness. Scientists have developed a new method to analyze sleep and wake states by detecting ultra-fast neuronal activity [...]
AI Reveals Health Secrets Through Facial Temperature Mapping
Researchers have found that different facial temperatures correlate with chronic illnesses like diabetes and high blood pressure, and these can be detected using AI with thermal cameras. They highlight the potential of this technology [...]
Breakthrough in aging research: Blocking IL-11 extends lifespan and improves health in mice
In a recent study published in the journal Nature, a team of researchers used murine models and various pharmacological and genetic approaches to examine whether pro-inflammatory signaling involving interleukin (IL)-11, which activates signaling molecules such [...]
Promise for a universal influenza vaccine: Scientists validate theory using 1918 flu virus
New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine—a so-called "one and done" vaccine that confers lifetime immunity against an evolving virus. The study, [...]
New Projects Aim To Pioneer the Future of Neuroscience
One study will investigate the alterations in brain activity at the cellular level caused by psilocybin, the psychoactive substance found in “magic mushrooms.” How do neurons respond to the effects of magic mushrooms? What [...]
Decoding the Decline: Scientific Insights Into Long COVID’s Retreat
Research indicates a significant reduction in long COVID risk, largely due to vaccination and the virus’s evolution. The study analyzes data from over 441,000 veterans, showing lower rates of long COVID among vaccinated individuals compared [...]
Silicon Transformed: A Breakthrough in Laser Nanofabrication
A new method enables precise nanofabrication inside silicon using spatial light modulation and laser pulses, creating advanced nanostructures for potential use in electronics and photonics. Silicon, the cornerstone of modern electronics, photovoltaics, and photonics, [...]
Caught in the actinium: New research could help design better cancer treatments
The element actinium was first discovered at the turn of the 20th century, but even now, nearly 125 years later, researchers still don't have a good grasp on the metal's chemistry. That's because actinium [...]
Innovative Light-Controlled Drugs Could Revolutionize Neuropathic Pain Treatment
A team of researchers from the Institute for Bioengineering of Catalonia (IBEC) has developed light-activated derivatives of the anti-epileptic drug carbamazepine to treat neuropathic pain. Light can be harnessed to target drugs to specific [...]
Green Gold: Turning E-Waste Into a Treasure Trove of Rare Earth Metals
Scientists are developing a process inspired by nature that efficiently recovers europium from old fluorescent lamps. The approach could lead to the long-awaited recycling of rare earth metals. A small molecule that naturally serves [...]
Cambridge Study: AI Chatbots Have an “Empathy Gap,” and It Could Be Dangerous
A new study suggests a framework for “Child Safe AI” in response to recent incidents showing that many children perceive chatbots as quasi-human and reliable. A study has indicated that AI chatbots often exhibit [...]
Nanoparticle-based delivery system could offer treatment for diabetics with rare insulin allergy
Up to 3% of people with diabetes have an allergic reaction to insulin. A team at Forschungszentrum Jülich has now studied a method that could be used to deliver the active substance into the [...]